• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).人类 CD161 蛋白(NKRP1A/KLRB1)识别 LLT1 蛋白的分子基础。
J Biol Chem. 2011 Jul 8;286(27):23823-30. doi: 10.1074/jbc.M110.214254. Epub 2011 May 13.
2
Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.前列腺癌细胞上LLT1(OCIL,CLEC2D)的过表达通过LLT1-NKRP1A(CD161)相互作用抑制自然杀伤细胞介导的杀伤作用。
Oncotarget. 2016 Oct 18;7(42):68650-68661. doi: 10.18632/oncotarget.11896.
3
Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A.人凝集素样转录本 1(LLT1)的细胞外结构域的晶体结构,该结构域为自然杀伤细胞受体-P1A 的配体。
Eur J Immunol. 2015 Jun;45(6):1605-13. doi: 10.1002/eji.201545509. Epub 2015 Apr 28.
4
Biological and Clinical Significance of Human NKRP1A/LLT1 Receptor/Ligand Interactions.人类NKRP1A/LLT1受体/配体相互作用的生物学和临床意义
Crit Rev Immunol. 2018;38(6):479-489. doi: 10.1615/CritRevImmunol.2019029559.
5
LLT1-CD161 Interaction in Cancer: Promises and Challenges.LLT1-CD161 相互作用在癌症中的应用:前景与挑战。
Front Immunol. 2022 Feb 4;13:847576. doi: 10.3389/fimmu.2022.847576. eCollection 2022.
6
Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.前沿:凝集素样转录本1是CD161受体的配体。
J Immunol. 2005 Dec 15;175(12):7791-5. doi: 10.4049/jimmunol.175.12.7791.
7
High-level expression and purification of soluble form of human natural killer cell receptor NKR-P1 in HEK293S GnTI cells.人自然杀伤细胞受体NKR-P1可溶性形式在HEK293S GnTI细胞中的高效表达与纯化
Protein Expr Purif. 2017 Dec;140:36-43. doi: 10.1016/j.pep.2017.07.016. Epub 2017 Jul 27.
8
A Role of NKR-P1A (CD161) and Lectin-like Transcript 1 in Natural Cytotoxicity against Human Articular Chondrocytes.NKR-P1A(CD161)和凝集素样转录本 1 在人关节软骨细胞自然细胞毒性中的作用。
J Immunol. 2018 Jan 15;200(2):715-724. doi: 10.4049/jimmunol.1700387. Epub 2017 Dec 6.
9
The c.503T>C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules.人类KLRB1基因中的c.503T>C多态性改变了CD161分子的配体结合和抑制潜能。
PLoS One. 2015 Aug 26;10(8):e0135682. doi: 10.1371/journal.pone.0135682. eCollection 2015.
10
LLT1-mediated activation of IFN-gamma production in human natural killer cells involves ERK signalling pathway.LLT1 通过激活 ERK 信号通路介导人自然杀伤细胞中 IFN-γ的产生。
Scand J Immunol. 2010 Mar;71(3):210-9. doi: 10.1111/j.1365-3083.2009.02367.x.

引用本文的文献

1
Immunobiology roles of the human CD161 receptor in T cells.人类CD161受体在T细胞中的免疫生物学作用。
Front Immunol. 2025 Aug 14;16:1648305. doi: 10.3389/fimmu.2025.1648305. eCollection 2025.
2
KLRB1 expression in nasopharyngeal mucosa as a prognostic biomarker in COVID-19 patients.KLRB1在鼻咽黏膜中的表达作为COVID-19患者的预后生物标志物
Sci Rep. 2025 Jan 24;15(1):3079. doi: 10.1038/s41598-025-86846-7.
3
Recognition of Self and Viral Ligands by NK Cell Receptors.自然杀伤细胞受体对自身和病毒配体的识别。
Immunol Rev. 2025 Jan;329(1):e13435. doi: 10.1111/imr.13435.
4
The shared circulating diagnostic biomarkers and molecular mechanisms of systemic lupus erythematosus and inflammatory bowel disease.系统性红斑狼疮和炎症性肠病的共享循环诊断生物标志物和分子机制。
Front Immunol. 2024 May 7;15:1354348. doi: 10.3389/fimmu.2024.1354348. eCollection 2024.
5
Contributions of the early-life microbiome to childhood atopy and asthma development.早期微生物组对儿童特应性和哮喘发展的影响。
Semin Immunol. 2023 Sep;69:101795. doi: 10.1016/j.smim.2023.101795. Epub 2023 Jun 26.
6
The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56 NK cells.抑制性受体 TIGIT 调节 NK 细胞功能,并在人肝内 CD56NK 细胞中上调。
Front Immunol. 2023 Feb 9;14:1117320. doi: 10.3389/fimmu.2023.1117320. eCollection 2023.
7
A pan-cancer and single-cell sequencing analysis of CD161, a promising onco-immunological biomarker in tumor microenvironment and immunotherapy.泛癌症和单细胞测序分析 CD161,一种有前途的肿瘤微环境和免疫治疗中的肿瘤免疫生物标志物。
Front Immunol. 2022 Dec 22;13:1040289. doi: 10.3389/fimmu.2022.1040289. eCollection 2022.
8
Structure of the human NK cell NKR-P1:LLT1 receptor:ligand complex reveals clustering in the immune synapse.人自然杀伤细胞 NKR-P1:LLT1 受体-配体复合物的结构:揭示免疫突触中的聚集。
Nat Commun. 2022 Aug 26;13(1):5022. doi: 10.1038/s41467-022-32577-6.
9
Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm.基于 WGCNA 和 LASSO 算法的肝癌巨噬细胞相关基因特征的预后、免疫特征和免疫治疗生物标志物的综合分子分析。
Front Immunol. 2022 May 27;13:843408. doi: 10.3389/fimmu.2022.843408. eCollection 2022.
10
LLT1-CD161 Interaction in Cancer: Promises and Challenges.LLT1-CD161 相互作用在癌症中的应用:前景与挑战。
Front Immunol. 2022 Feb 4;13:847576. doi: 10.3389/fimmu.2022.847576. eCollection 2022.

本文引用的文献

1
Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis.幼年特发性关节炎患者滑液中CD4+CD161+ T细胞Th17表型短暂性的证据。
Arthritis Rheum. 2011 Aug;63(8):2504-15. doi: 10.1002/art.30332.
2
Characterization of alternatively spliced transcript variants of CLEC2D gene.CLEC2D 基因剪接转录变体的特征。
J Biol Chem. 2010 Nov 12;285(46):36207-15. doi: 10.1074/jbc.M110.179622. Epub 2010 Sep 14.
3
CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC.CD161 是所有人类产生白细胞介素 17 的 T 细胞亚群的标志物,由 RORC 诱导。
Eur J Immunol. 2010 Aug;40(8):2174-81. doi: 10.1002/eji.200940257.
4
Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytes.C 型凝集素样受体 NKp65 和 KACL 的相互作用促进了人类角质形成细胞的特异性免疫识别。
Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5100-5. doi: 10.1073/pnas.0913108107. Epub 2010 Mar 1.
5
LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study.LY2439821,一种人源化抗白细胞介素-17单克隆抗体,用于治疗类风湿性关节炎患者:一项I期随机、双盲、安慰剂对照的概念验证研究。
Arthritis Rheum. 2010 Apr;62(4):929-39. doi: 10.1002/art.27334.
6
Structure of natural killer cell receptor KLRG1 bound to E-cadherin reveals basis for MHC-independent missing self recognition.与E-钙黏蛋白结合的自然杀伤细胞受体KLRG1的结构揭示了不依赖MHC的缺失自我识别的基础。
Immunity. 2009 Jul 17;31(1):35-46. doi: 10.1016/j.immuni.2009.04.019.
7
Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation.循环和肠道驻留的人类辅助性T细胞17(Th17)表达CD161并促进肠道炎症。
J Exp Med. 2009 Mar 16;206(3):525-34. doi: 10.1084/jem.20081712. Epub 2009 Mar 9.
8
Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor.产生人类白细胞介素17的细胞源自CD161+CD4+ T细胞前体。
J Exp Med. 2008 Aug 4;205(8):1903-16. doi: 10.1084/jem.20080397. Epub 2008 Jul 28.
9
PILAR is a novel modulator of human T-cell expansion.PILAR是一种新型的人类T细胞扩增调节剂。
Blood. 2008 Aug 15;112(4):1259-68. doi: 10.1182/blood-2007-12-130773. Epub 2008 Jun 12.
10
CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.CD94-NKG2A对与HLA I类前导序列结合的人类白细胞抗原(HLA)-E的识别。
J Exp Med. 2008 Mar 17;205(3):725-35. doi: 10.1084/jem.20072525. Epub 2008 Mar 10.

人类 CD161 蛋白(NKRP1A/KLRB1)识别 LLT1 蛋白的分子基础。

Molecular basis for LLT1 protein recognition by human CD161 protein (NKRP1A/KLRB1).

机构信息

Laboratory of Biomolecular Science, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-12, Nishi-6, Kita-ku, Sapporo 060-0812, Japan.

出版信息

J Biol Chem. 2011 Jul 8;286(27):23823-30. doi: 10.1074/jbc.M110.214254. Epub 2011 May 13.

DOI:10.1074/jbc.M110.214254
PMID:21572041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3129164/
Abstract

Human Th17 cells express high levels of CD161, a member of the killer cell lectin-like receptor (KLR) family (also referred to as NK receptor-P1A (NKRP1A) or KLRB1), as a representative marker. CD161 is also expressed on natural killer (NK) cells and NKT cells. Lectin-like transcript 1 (LLT1), another KLR family member, was recently identified as a ligand for CD161. This interaction may play pivotal roles in the immunomodulatory functions of Th17 cells as well as those of NK and NKT cells. However, the molecular basis for the interaction is poorly understood. Here we show that the extracellular domain of CD161 bound directly to LLT1 with a K(d) of 48 μM and with the fast kinetics typical of cell-cell recognition receptors. Mutagenesis revealed that the similar membrane-distal β-sheet and loop regions of both CD161 and LLT1 were utilized for the binding, and notably, these regions correspond to the ligand-binding sites for major histocompatibility complex (MHC)-recognizing KLRs. Furthermore, we found a pair of detrimental mutations for both molecules that restored the binding. These results reveal a new template model for the recognition mode between the KLR family members and provide insights into the molecular mechanism underlying Th17/NK/NKT-mediated immune responses.

摘要

人 Th17 细胞表达高水平的 CD161,CD161 是杀伤细胞凝集素样受体 (KLR) 家族的成员(也称为 NK 受体-P1A (NKRP1A) 或 KLRB1),作为代表性标志物。CD161 也在自然杀伤 (NK) 细胞和 NKT 细胞上表达。另一个 KLR 家族成员,凝集素样转录本 1 (LLT1),最近被鉴定为 CD161 的配体。这种相互作用可能在 Th17 细胞以及 NK 和 NKT 细胞的免疫调节功能中发挥关键作用。然而,这种相互作用的分子基础了解甚少。在这里,我们表明 CD161 的细胞外结构域以 48 μM 的 K(d)直接与 LLT1 结合,具有细胞间识别受体的快速动力学特征。突变分析表明,CD161 和 LLT1 的类似膜远β-片层和环区都用于结合,值得注意的是,这些区域对应于主要组织相容性复合体 (MHC)-识别 KLR 的配体结合位点。此外,我们发现这两个分子都有一对有害突变,恢复了结合。这些结果揭示了 KLR 家族成员之间识别模式的新模板模型,并为 Th17/NK/NKT 介导的免疫反应的分子机制提供了深入了解。